Article info
Poster Presentations
Immune-stimulants and immune modulators
P857 ONM-500 – a novel STING-activating therapeutic nanovaccine platform for cancer immunotherapy
Citation
P857 ONM-500 – a novel STING-activating therapeutic nanovaccine platform for cancer immunotherapy
Publication history
- First published April 15, 2020.
Online issue publication
April 15, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.